Alphabet as of March 31, 2024
Portfolio Holdings for Alphabet
Alphabet holds 43 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gitlab Class A Com (GTLB) | 22.6 | $569M | 9.8M | 58.32 | |
| Crowdstrike Hldgs Cl A (CRWD) | 10.9 | $274M | 856k | 320.59 | |
| Dex (DXCM) | 9.9 | $248M | 1.8M | 138.70 | |
| Arm Holdings Sponsored Adr (ARM) | 9.7 | $245M | 2.0M | 124.99 | |
| Freshworks Class A Com (FRSH) | 8.9 | $225M | 12M | 18.21 | |
| Revolution Medicines (RVMD) | 6.8 | $171M | 5.3M | 32.23 | |
| Verve Therapeutics (VERV) | 6.5 | $164M | 12M | 13.28 | |
| Uipath Cl A (PATH) | 6.3 | $160M | 7.0M | 22.67 | |
| Prime Medicine (PRME) | 4.2 | $105M | 15M | 7.00 | |
| Snowflake Cl A (SNOW) | 3.4 | $87M | 536k | 161.60 | |
| Planet Labs Pbc Com Cl A (PL) | 3.2 | $82M | 32M | 2.55 | |
| Sana Biotechnology (SANA) | 1.1 | $28M | 2.8M | 10.00 | |
| Adagio Therapeutics (IVVD) | 0.8 | $20M | 4.5M | 4.44 | |
| Lyell Immunopharma | 0.5 | $13M | 5.9M | 2.23 | |
| Relay Therapeutics (RLAY) | 0.5 | $13M | 1.6M | 8.30 | |
| Beam Therapeutics (BEAM) | 0.4 | $11M | 322k | 33.04 | |
| Vera Therapeutics Cl A (VERA) | 0.4 | $10M | 241k | 43.12 | |
| Monte Rosa Therapeutics (GLUE) | 0.4 | $10M | 1.5M | 7.05 | |
| Desktop Metal Com Cl A | 0.4 | $9.7M | 11M | 0.88 | |
| Tscan Therapeutics (TCRX) | 0.3 | $8.6M | 1.1M | 7.94 | |
| Illumina (ILMN) | 0.3 | $7.3M | 54k | 137.32 | |
| Oscar Health Cl A (OSCR) | 0.3 | $7.2M | 482k | 14.87 | |
| Dianthus Therapeutics (DNTH) | 0.2 | $6.3M | 209k | 30.00 | |
| Fractyl Health (GUTS) | 0.2 | $4.9M | 663k | 7.40 | |
| Rapt Therapeutics | 0.2 | $4.9M | 540k | 8.98 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $4.8M | 916k | 5.23 | |
| Autolus Therapeutics Spon Adr (AUTL) | 0.2 | $4.5M | 698k | 6.38 | |
| Barinthus Biotherapeutics Pl Ads (BRNS) | 0.1 | $3.6M | 1.5M | 2.38 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $3.4M | 501k | 6.71 | |
| Benson Hill Common Stock | 0.1 | $3.1M | 15M | 0.20 | |
| Kronos Bio | 0.1 | $1.9M | 1.4M | 1.30 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $1.8M | 641k | 2.87 | |
| EXACT Sciences Corporation (EXAS) | 0.1 | $1.6M | 23k | 69.06 | |
| Spero Therapeutics (SPRO) | 0.1 | $1.5M | 890k | 1.72 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.1 | $1.4M | 449k | 3.11 | |
| Alector (ALEC) | 0.0 | $1.1M | 176k | 6.02 | |
| Hyperfine Com Cl A (HYPR) | 0.0 | $899k | 899k | 1.00 | |
| Cortexyme (QNCX) | 0.0 | $201k | 189k | 1.06 | |
| Fulcrum Therapeutics (FULC) | 0.0 | $135k | 14k | 9.44 | |
| Repligen Corporation (RGEN) | 0.0 | $70k | 383.00 | 183.92 | |
| Mondee Holdings Class A Com (MONDQ) | 0.0 | $43k | 18k | 2.31 | |
| Cue Health (HLTHQ) | 0.0 | $5.1k | 27k | 0.19 | |
| Invitae (NVTAQ) | 0.0 | $0 | 236k | 0.00 |
